Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 941 | 6,209 | 2,513 | 309,060 | -1,949 |
| Depreciation Amortization | 523 | 438 | 284 | 362 | 345 |
| Income taxes - deferred | 471 | -5,156 | N/A | N/A | N/A |
| Accounts receivable | -1,851 | 953 | -2,185 | -977 | 137 |
| Other Working Capital | -1,521 | 593 | -1,969 | -634 | 117 |
| Other Operating Activity | 2,197 | -769 | 2,374 | -307,560 | 155 |
| Operating Cash Flow | $761 | $2,268 | $1,017 | $252 | $-1,194 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -872 | -727 | -182 | -377 | -398 |
| Investing Cash Flow | $-872 | $-727 | $-182 | $-377 | $-398 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250 | 5 | N/A |
| Debt Repayment | -68 | -955 | -54 | -24 | -24 |
| Common Stock Issued | 120 | 288 | 38 | N/A | N/A |
| Financing Cash Flow | $52 | $-667 | $234 | $-19 | $-24 |
| Beginning Cash Position | 3,011 | 2,136 | 1,068 | 1,212 | 2,827 |
| End Cash Position | 2,952 | 3,011 | 2,136 | 1,068 | 1,212 |
| Net Cash Flow | $-59 | $875 | $1,068 | $-144 | $-1,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | 761 | 2,268 | 1,017 | 252 | -1,194 |
| Capital Expenditure | -872 | -727 | -182 | -391 | -398 |
| Free Cash Flow | -111 | 1,542 | 835 | -139 | -1,592 |